Serum levels of PLA2G2A in patients with chronic HBV, HBV-induced liver cirrhosis, and HCC (HBV-HCC) were enhanced compared to healthy donors [10]. This evidence concerns the gene PLA2G2A and hepatocellular carcinoma.